Pharma Reviews: Cipla, Lupin, Sun Pharma to make, sell low-cost versions of Lilly's COVID-19 drug

US pharmaceutical major Eli Lilly and Company (Lilly) has issued royalty-free, non-exclusive voluntary licenses to Indian generic firms Cipla Ltd, ...
Read more: Cipla, Lupin, Sun Pharma to make, sell low-cost versions of Lilly's COVID-19 drug